Ferris, Frederick L.
National Institutes of Health · National Eye Institute
21 papers on CoChatORCID 0000-0002-4933-0639
Most cited papers
- Verified
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science
Retinal Diseases and TreatmentsComplement system in diseases
Cited by 4,492
- Verified
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 1,715
- Verified
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology
Retinal Diseases and TreatmentsRetinal Imaging and Analysis
Cited by 839
- Verified
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
Maguire, M. G., Martin, D. F., Ying, G.-S., Jaffe, G. J., Daniel, E., Grunwald, J. E., Toth, C. A., Ferris, F. L., & Fine, S. L. (2016) · Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 708
- Verified
Senile macular degeneration: a case-control study
HYMAN, L. G., LILIENFELD, A. M., FERRIS, F. L., & FINE, S. L. (1983) · American Journal of Epidemiology
Retinal Diseases and TreatmentsRetinal Imaging and Analysis
Cited by 587
- Verified
Age-related macular degeneration
Coleman, H. R., Chan, C.-C., Ferris, F. L., & Chew, E. Y. (2008) · The Lancet
Retinal Diseases and TreatmentsRetinal Imaging and Analysis
Cited by 542
- Verified
Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
Chen, W., Stambolian, D., Edwards, A. O., Branham, K. E., Othman, M., Jakobsdottir, J., Tosakulwong, N., Pericak-Vance, M. A., Campochiaro, P. A., Klein, M. L., et al. (2010) · Proceedings of the National Academy of Sciences
Retinal Diseases and TreatmentsGenetic Associations and Epidemiology
Cited by 506
- Verified
Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology
Retinal Diseases and TreatmentsAntioxidant Activity and Oxidative Stress
Cited by 415
- Verified
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Gross, J. G., Glassman, A. R., Liu, D., Sun, J. K., Antoszyk, A. N., Baker, C. W., Bressler, N. M., Elman, M. J., Ferris, F. L., Gardner, T. W., et al. (2018) · JAMA Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 404
- Verified
Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS Report No. 11
Bressler, N. M., Sb, B., Congdon, N. G., Ferris, F. L., Friedman, D. S., Klein, R., Lindblad, A. S., Milton, R. C., & Seddon, J. M. (2003) · Archives of Ophthalmology
Retinal Diseases and TreatmentsRetinal Imaging and Analysis
Cited by 374
- Verified
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium *
Csaky, K. G., Richman, E. A., & Ferris, F. L. (2008) · Investigative Opthalmology & Visual Science
Statistical Methods in Clinical TrialsRetinal Diseases and Treatments
Cited by 265
- Verified
Report from the NEI/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases
Csaky, K., Ferris, F., Chew, E. Y., Nair, P., Cheetham, J. K., & Duncan, J. L. (2017) · Investigative Opthalmology & Visual Science
Retinal Diseases and TreatmentsRetinal Development and Disorders
Cited by 231
- Verified
Visual acuity as an outcome measure in clinical trials of retinal diseases
Beck, R. W., Maguire, M. G., Bressler, N. M., Glassman, A. R., Lindblad, A. S., & Ferris, F. L. (2007) · Ophthalmology
Statistical Methods in Clinical TrialsRetinal Diseases and Treatments
Cited by 188
- Verified
Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28
Cukras, C., Agrón, E., Klein, M. L., Ferris, F. L., Chew, E. Y., Gensler, G., & Wong, W. T. (2010) · Ophthalmology
Retinal Diseases and TreatmentsRetinal Imaging and Analysis
Cited by 170
- Verified
Hypomethylation of the IL17RC Promoter Associates with Age-Related Macular Degeneration
Wei, L., Liu, B., Tuo, J., Shen, D., Chen, P., Li, Z., Liu, X., Ni, J., Dagur, P., Sen, H. N., et al. (2012) · Cell Reports
Retinal Diseases and TreatmentsEpigenetics and DNA Methylation
Cited by 167
- Verified
Complement Component C5a Promotes Expression of IL-22 and IL-17 from Human T Cells and Its Implication in Age-Related Macular Degeneration
Liu, B., Wei, L., Meyerle, C., Tuo, J., Sen, H. N., Li, Z., Chakrabarty, S., Agron, E., Chan, C.-C., Klein, M. L., et al. (2011) · Journal of Translational Medicine
Complement system in diseasesRetinal Diseases and Treatments
Cited by 164
- Verified
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
Bressler, S. B., Glassman, A. R., Almukhtar, T., Bressler, N. M., Ferris, F. L., Googe, J. M., Gupta, S. K., Jampol, L. M., Melia, M., & Wells, J. A. (2016) · American Journal of Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 139
- Verified
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 130
- Verified
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials
Daniel, E., Pan, W., Ying, G.-S., Kim, B. J., Grunwald, J. E., Ferris, F. L., Jaffe, G. J., Toth, C. A., Martin, D. F., Fine, S. L., et al. (2018) · Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 119
- Verified
The LOC387715 Polymorphism and Age-Related Macular Degeneration: Replication in Three Case–Control Samples
Ross, R. J., Bojanowski, C. M., Wang, J. J., Chew, E. Y., Rochtchina, E., Ferris, F. L., Mitchell, P., Chan, C.-C., & Tuo, J. (2007) · Investigative Opthalmology & Visual Science
Retinal Diseases and TreatmentsRetinal Development and Disorders
Cited by 75
- Verified
The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples
Tuo, J., Ross, R. J., Reed, G. F., Yan, Q., Wang, J. J., Bojanowski, C. M., Chew, E. Y., Feng, X., Olsen, T. W., Ferris, F. L., et al. (2008) · Ophthalmology
Retinal Diseases and TreatmentsRetinal Development and Disorders
Cited by 63
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free